Mercier Johanna reported option exercise involving 25,000 derivative units of GILEAD SCIENCES, INC. at $0.00 for $0 on Nov 16, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Comm & Corp Aff Officer
Chief Comm & Corp Aff Officer
Filed Nov 17, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
25,000Non-qualified Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
44,960Direct
Trade date
Nov 16, 2026Option exercise
Filed
Nov 17, 2026, 8:32 PM ET2-day reporting delay
Accession
0001782135-26-000037Code M · Transaction 405080
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 16, 2026Sell13,922$169.97−$2,366,337.65Trade 405077
Nov 16, 2026Sell13,178$171.09−$2,254,672.78Trade 405078
Nov 16, 2026Sell900$171.69−$154,517.04Trade 405079
Nov 16, 2026Option exercise25,000$72.34$1,808,500Trade 405076
5 transaction rows in this filing. Joint filers share the same rows.

GILD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
GILD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −8.3%1w ago −0.6%1d ago −1.3%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2: Sale prices for the transactions reported range from $169.57 to $170.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3: Sale prices for the transactions reported range from $170.58 to $171.53. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4: Sale prices for the transactions reported range from $171.65 to $171.69. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5: The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.